Intervention
Exendin-9,39
ClinicalTrials.gov intervention label
Clinical trials
4 shownEndogenous GLP-1 Secretion on Islet Function in People With and Without Type 2 DiabetesNCT04466618 · 2021-04-15
COMPLETEDExendin-9,39 and Satiety After Bariatric SurgeryNCT02779075 · 2016-06-01
COMPLETEDThe Effect of Bariatric Surgery on Metabolism, the Metabolome and Microbiome in Patients With Type 2 DiabetesNCT02762708 · 2016-03-01
COMPLETEDA Dose-response of the Effects of Exendin-9,39 on GI Symptoms and Food IntakeNCT02128581 · 2014-05-01
COMPLETEDCommon conditions
Leading sponsors
Trial status mix
COMPLETED4
Phase mix
NA1
PHASE11
PHASE21
PHASE31
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.